KPL · Kwality Pharmaceuticals Limited · Financials
Market Cap
39.66B INR
Shares
10.38M
Volume · Nov 13
95.06K
Avg daily vol (3M)
44.99K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
5.03B
+35.9%
FY2026
Net Income
673.46M
+69%
FY2026
Operating Cash Flow
165.86M
-68.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 6.24B | 5.03B | 3.7B |
| INR | 204.42M | 198.1M | 182.9M |
| INR | 110.24M | 109.7M | 98.78M |
| INR | 1.3B | 894.92M | 541.4M |
| INR | 342.6M | 221.46M | 143.37M |
| INR | 959.6M | 673.46M | 398.45M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.